NHS to Offer Improved Stop Smoking Pill in England

Nov.15.2024
NHS to Offer Improved Stop Smoking Pill in England
NHS will start offering an "improved" stop smoking pill to tens of thousands of people in England who want to quit cigarettes.

According to a recent report by the BBC, the National Health Service (NHS) in the UK will begin offering an "improved" stop smoking pill to tens of thousands of people in England who are looking to quit smoking.

 

The NHS has stated that Varenicline is as effective as e-cigarettes and more effective than nicotine replacement gum or patches.

 

This medication can suppress nicotine addiction and was previously marketed under the brand name Champix on the NHS several years ago. However, it was withdrawn due to some impurity issues. The new version has now been approved as safe.

 

Officials stated that e-cigarettes are sometimes provided, typically by local NHS stop smoking services, with an initial e-cigarette starter kit provided for approximately two weeks.

 

Varenicline is a prescription medication, which means people cannot purchase it over the counter at a pharmacy or supermarket and instead need to see their general practitioner (GP) or NHS stop smoking service to obtain it. It works by reducing cravings for nicotine and blocking its effects on the brain, while also helping to alleviate withdrawal symptoms such as irritability or difficulty sleeping.

 

The NHS states that it has been proven to help approximately one quarter of people quit smoking for at least six months when used in conjunction with behavioral support, such as counseling. The study suggests that this could help over 85,000 people quit smoking each year and potentially prevent around 9,500 smoking-related deaths in the next five years.

 

Health and Social Care Secretary Wes Streeting said: "The rollout of this pill can save the NHS millions of pounds, save appointments to help other patients be seen faster and save lives."

 

NHS CEO Amanda Pritchard announced at the annual NHS Providers conference that this drug could be a "game-changer" for those looking to quit smoking.

 

Due to e-cigarettes not being licensed as medication, general practitioners are unable to prescribe e-cigarettes for individuals attempting to quit smoking unless approved by the local NHS. However, some local governments do indeed provide e-cigarettes for smokers wanting to quit.

 

The guidelines suggest that people first try to obtain licensed smoking cessation medications, even though e-cigarettes are recognized as a smoking cessation aid. The harms of e-cigarettes are far less than smoking.

 

However, health experts unanimously agree that people should not start using e-cigarettes unless it is for smoking cessation.

 

Hazel Cheeseman, chief executive of Action on Smoking and Health, said access to services was variable.

 

"Wherever a smoker lives, they should be able to access the most effective forms of treatment to help them stop," she said.

 

"Improving access to varenicline will be a positive step forward to help prevent the tens of thousands of deaths caused by smoking. However, a drug alone will not transform smoking rates. Services are needed to support smokers and prescribe these products."

 

"The NHS has done a good job in setting up in-hospital support to help people quit smoking, which complements the services provided in the community, said Hazel Cheeseman. "But gaps remain around the country, with services often in peril as local NHS organizations try to balance the books."

 

US: Ohio Appeals Court Backs Local Tobacco Control: Strikes Down State Law Limiting City Regulations
US: Ohio Appeals Court Backs Local Tobacco Control: Strikes Down State Law Limiting City Regulations
An Ohio appeals court has struck down a state law that blocked local governments from enacting tobacco regulations, ruling that cities can govern tobacco under their home-rule authority. The state legislature had previously overridden the governor’s veto of the law. The decision bolsters local efforts to address public health challenges through independent tobacco control measures.
Jul.10 by 2FIRSTS.ai
Although not yet approved by the FDA, Altria still plans to launch its new nicotine pouch product, on! PLUS™, in the U.S
Although not yet approved by the FDA, Altria still plans to launch its new nicotine pouch product, on! PLUS™, in the U.S
Altria announced that its subsidiary, Helix, will launch a new nicotine pouch product, on! PLUS™, in the U.S. this fall, with the initial markets covering North Carolina, Texas, and Florida. The product has not yet been approved by the FDA. It is noteworthy that the launch time and regions for on! PLUS™ are highly similar to those of BAT's planned disposable e-cigarette, Vuse One.
Aug.25
WHO Criticized for Questioning FDA’s Harm Reduction Assessment, Accused of Defying Scientific Consensus
WHO Criticized for Questioning FDA’s Harm Reduction Assessment, Accused of Defying Scientific Consensus
A World Health Organization (WHO) official, Dr. Roa, recently questioned the U.S. Food and Drug Administration’s (FDA) scientific assessment of e-cigarettes and nicotine pouches, claiming there was no independent consensus and suggesting its conclusions may have been influenced by the industry. Her remarks contradict the consensus of leading international scientific bodies and are seen as a direct challenge to FDA’s credibility and to the integrity of public health science.
Aug.20 by 2FIRSTS.ai
JTI Launches Limited Edition Ploom X Advanced in South Korea, Priced at Around $50
JTI Launches Limited Edition Ploom X Advanced in South Korea, Priced at Around $50
On July 1, JTI Korea launched the Ploom X Advanced Limited Edition Ora Ito Red, a red heat-not-burn device developed in collaboration with designer Ora Ito. The standalone device is priced at approximately $50.
Jul.01 by 2FIRSTS.ai
KT&G Supplier ITM Semiconductor Establishes Manufacturing Plant in Indonesia to Meet Market Expansion and Order Demand
KT&G Supplier ITM Semiconductor Establishes Manufacturing Plant in Indonesia to Meet Market Expansion and Order Demand
ITM Semiconductor announced on August 14 that it has set up a heated tobacco manufacturing plant in Cikarang, Indonesia, aiming to boost product supply in response to new orders from KT&G and ongoing market expansion.
Aug.14 by 2FIRSTS.ai
Malaysia's Negeri Sembilan Supports E-Cigarette Ban, Emphasizes the Need for Supporting Legislation for Enforcement
Malaysia's Negeri Sembilan Supports E-Cigarette Ban, Emphasizes the Need for Supporting Legislation for Enforcement
The Menteri Besar of Negeri Sembilan, Aminuddin, stated that the state's ban on the sale and use of e-cigarettes requires clear regulations and laws for effective implementation.
Aug.06 by 2FIRSTS.ai